65 results
8-K
EX-2.1
ANGO
Angiodynamic Inc
14 Jun 23
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:39pm
way related to the employment or retention of any employees, former employees, directors or independent contractors of Seller; and
(j) all obligations … , that Seller shall reimburse Purchaser for an amount equal to one-half of the R&W Policy Retention Amount to the extent required pursuant to Section 11.9
8-K
EX-99.1
ANGO
Angiodynamic Inc
30 Mar 23
AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance
7:30am
a $4.2 million, or $0.08 per share benefit, respectively, related to the reimbursement of certain expenses under the employee retention credit as part … of certain expenses under the employee retention credit as part of the CARES Act.
Adjusted EBITDA, excluding the items shown in the reconciliation table
8-K
EX-10.1
07xxg yxnw
31 Aug 22
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-99.1
yqry3 1wj
12 Jul 22
AngioDynamics Reports Fiscal Year 2022 Fourth Quarter
8:04am
8-K
EX-99.1
p09yb
7 Apr 22
AngioDynamics Reports Fiscal 2022 Third Quarter Financial Results; Reaffirms Fiscal Year 2022 Guidance
7:22am
8-K
EX-10.1
bqdnxg2
6 Jun 19
Entry into a Material Definitive Agreement
4:37pm
8-K
EX-2.1
z64juv 2u
18 Apr 19
Entry into a Material Definitive Agreement
8:04am